Table of Contents

1 Market Overview

1.1 Hip Osteoarthritis Pain Drug Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Hip Osteoarthritis Pain Drug Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Oral

1.2.3 Injection

1.2.4 External

1.3 Market Analysis by Application

1.3.1 Overview: Global Hip Osteoarthritis Pain Drug Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Medical Care

1.3.3 Personal Care

1.4 Overview of Global Hip Osteoarthritis Pain Drug Market

1.4.1 Global Hip Osteoarthritis Pain Drug Market Status and Outlook (2015-2025)

1.4.2 North America (United States, Canada and Mexico)

1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)

1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.5 South America, Middle East & Africa

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Pfizer Details

2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Pfizer SWOT Analysis

2.1.4 Pfizer Product and Services

2.1.5 Pfizer Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.2 Horizon Pharma

2.2.1 Horizon Pharma Details

2.2.2 Horizon Pharma Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Horizon Pharma SWOT Analysis

2.2.4 Horizon Pharma Product and Services

2.2.5 Horizon Pharma Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.3 Bayer

2.3.1 Bayer Details

2.3.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Bayer SWOT Analysis

2.3.4 Bayer Product and Services

2.3.5 Bayer Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.4 Johnson and Johnson

2.4.1 Johnson and Johnson Details

2.4.2 Johnson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Johnson and Johnson SWOT Analysis

2.4.4 Johnson and Johnson Product and Services

2.4.5 Johnson and Johnson Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.5 Sanofi

2.5.1 Sanofi Details

2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Sanofi SWOT Analysis

2.5.4 Sanofi Product and Services

2.5.5 Sanofi Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.6 GlaxoSmithKline

2.6.1 GlaxoSmithKline Details

2.6.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 GlaxoSmithKline SWOT Analysis

2.6.4 GlaxoSmithKline Product and Services

2.6.5 GlaxoSmithKline Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.7 Mylan

2.7.1 Mylan Details

2.7.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Mylan SWOT Analysis

2.7.4 Mylan Product and Services

2.7.5 Mylan Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.8 Novartis

2.8.1 Novartis Details

2.8.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Novartis SWOT Analysis

2.8.4 Novartis Product and Services

2.8.5 Novartis Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.9 Eli Lilly

2.9.1 Eli Lilly Details

2.9.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Eli Lilly SWOT Analysis

2.9.4 Eli Lilly Product and Services

2.9.5 Eli Lilly Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.10 Abbott

2.10.1 Abbott Details

2.10.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 Abbott SWOT Analysis

2.10.4 Abbott Product and Services

2.10.5 Abbott Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.11 Tide Pharmaceutical

2.11.1 Tide Pharmaceutical Details

2.11.2 Tide Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis

2.11.3 Tide Pharmaceutical SWOT Analysis

2.11.4 Tide Pharmaceutical Product and Services

2.11.5 Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.12 Abiogen Pharma

2.12.1 Abiogen Pharma Details

2.12.2 Abiogen Pharma Major Business and Total Revenue (Financial Highlights) Analysis

2.12.3 Abiogen Pharma SWOT Analysis

2.12.4 Abiogen Pharma Product and Services

2.12.5 Abiogen Pharma Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.13 Daiichi Sankyo

2.13.1 Daiichi Sankyo Details

2.13.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis

2.13.3 Daiichi Sankyo SWOT Analysis

2.13.4 Daiichi Sankyo Product and Services

2.13.5 Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.14 Iroko Pharmaceuticals

2.14.1 Iroko Pharmaceuticals Details

2.14.2 Iroko Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis

2.14.3 Iroko Pharmaceuticals SWOT Analysis

2.14.4 Iroko Pharmaceuticals Product and Services

2.14.5 Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.15 Astellas Pharma

2.15.1 Astellas Pharma Details

2.15.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis

2.15.3 Astellas Pharma SWOT Analysis

2.15.4 Astellas Pharma Product and Services

2.15.5 Astellas Pharma Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.16 TEVA

2.16.1 TEVA Details

2.16.2 TEVA Major Business and Total Revenue (Financial Highlights) Analysis

2.16.3 TEVA SWOT Analysis

2.16.4 TEVA Product and Services

2.16.5 TEVA Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.17 Hengrui Pharmaceutical

2.17.1 Hengrui Pharmaceutical Details

2.17.2 Hengrui Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis

2.17.3 Hengrui Pharmaceutical SWOT Analysis

2.17.4 Hengrui Pharmaceutical Product and Services

2.17.5 Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.18 Almatica Pharma

2.18.1 Almatica Pharma Details

2.18.2 Almatica Pharma Major Business and Total Revenue (Financial Highlights) Analysis

2.18.3 Almatica Pharma SWOT Analysis

2.18.4 Almatica Pharma Product and Services

2.18.5 Almatica Pharma Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

3 Sales, Revenue and Market Share by Manufacturer

3.1 Global Hip Osteoarthritis Pain Drug Sales and Market Share by Manufacturer (2018-2019)

3.2 Global Hip Osteoarthritis Pain Drug Revenue and Market Share by Manufacturer (2018-2019)

3.3 Market Concentration Rate

3.3.1 Top 3 Hip Osteoarthritis Pain Drug Manufacturer Market Share in 2019

3.3.2 Top 6 Hip Osteoarthritis Pain Drug Manufacturer Market Share in 2019

3.4 Market Competition Trend

4 Global Market Analysis by Regions

4.1 Global Hip Osteoarthritis Pain Drug Sales, Revenue and Market Share by Regions

4.1.1 Global Hip Osteoarthritis Pain Drug Sales and Market Share by Regions (2015-2020)

4.1.2 Global Hip Osteoarthritis Pain Drug Revenue and Market Share by Regions (2015-2020)

4.2 North America Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

4.3 Europe Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

4.4 Asia-Pacific Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

4.5 South America Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

4.6 Middle East and Africa Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

5 North America by Country

5.1 North America Hip Osteoarthritis Pain Drug Sales, Revenue and Market Share by Country

5.1.1 North America Hip Osteoarthritis Pain Drug Sales and Market Share by Country (2015-2020)

5.1.2 North America Hip Osteoarthritis Pain Drug Revenue and Market Share by Country (2015-2020)

5.2 United States Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

5.3 Canada Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

5.4 Mexico Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

6 Europe by Country

6.1 Europe Hip Osteoarthritis Pain Drug Sales, Revenue and Market Share by Country

6.1.1 Europe Hip Osteoarthritis Pain Drug Sales and Market Share by Country (2015-2020)

6.1.2 Europe Hip Osteoarthritis Pain Drug Revenue and Market Share by Country (2015-2020)

6.2 Germany Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

6.3 UK Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

6.4 France Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

6.5 Russia Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

6.6 Italy Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Hip Osteoarthritis Pain Drug Sales, Revenue and Market Share by Regions

7.1.1 Asia-Pacific Hip Osteoarthritis Pain Drug Sales and Market Share by Regions (2015-2020)

7.1.2 Asia-Pacific Hip Osteoarthritis Pain Drug Revenue and Market Share by Regions (2015-2020)

7.2 China Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

7.3 Japan Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

7.4 Korea Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

7.5 India Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

7.6 Southeast Asia Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

7.7 Australia Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

8 South America by Country

8.1 South America Hip Osteoarthritis Pain Drug Sales, Revenue and Market Share by Country

8.1.1 South America Hip Osteoarthritis Pain Drug Sales and Market Share by Country (2015-2020)

8.1.2 South America Hip Osteoarthritis Pain Drug Revenue and Market Share by Country (2015-2020)

8.2 Brazil Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

8.3 Argentina Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Hip Osteoarthritis Pain Drug Sales, Revenue and Market Share by Country

9.1.1 Middle East & Africa Hip Osteoarthritis Pain Drug Sales and Market Share by Country (2015-2020)

9.1.2 Middle East & Africa Hip Osteoarthritis Pain Drug Revenue and Market Share by Country (2015-2020)

9.2 Saudi Arabia Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

9.3 Turkey Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

9.4 Egypt Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

9.5 South Africa Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

10 Market Segment by Type

10.1 Global Hip Osteoarthritis Pain Drug Sales and Market Share by Type (2015-2020)

10.2 Global Hip Osteoarthritis Pain Drug Revenue and Market Share by Type (2015-2020)

10.3 Global Hip Osteoarthritis Pain Drug Price by Type (2015-2020)

11 Global Hip Osteoarthritis Pain Drug Market Segment by Application

11.1 Global Hip Osteoarthritis Pain Drug Sales Market Share by Application (2015-2020)

11.2 Global Hip Osteoarthritis Pain Drug Revenue Market Share by Application (2015-2020)

11.3 Global Hip Osteoarthritis Pain Drug Price by Application (2015-2020)

12 Market Forecast

12.1 Global Hip Osteoarthritis Pain Drug Sales, Revenue and Growth Rate (2021-2025)

12.2 Hip Osteoarthritis Pain Drug Market Forecast by Regions (2021-2025)

12.2.1 North America Hip Osteoarthritis Pain Drug Market Forecast (2021-2025)

12.2.2 Europe Hip Osteoarthritis Pain Drug Market Forecast (2021-2025)

12.2.3 Asia-Pacific Hip Osteoarthritis Pain Drug Market Forecast (2021-2025)

12.2.4 South America Hip Osteoarthritis Pain Drug Market Forecast (2021-2025)

12.2.5 Middle East & Africa Hip Osteoarthritis Pain Drug Market Forecast (2021-2025)

12.3 Hip Osteoarthritis Pain Drug Market Forecast by Type (2021-2025)

12.3.1 Global Hip Osteoarthritis Pain Drug Sales Forecast by Type (2021-2025)

12.3.2 Global Hip Osteoarthritis Pain Drug Market Share Forecast by Type (2021-2025)

12.4 Hip Osteoarthritis Pain Drug Market Forecast by Application (2021-2025)

12.4.1 Global Hip Osteoarthritis Pain Drug Sales Forecast by Application (2021-2025)

12.4.2 Global Hip Osteoarthritis Pain Drug Market Share Forecast by Application (2021-2025)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

15.3 Disclaimer

15.4 About US

List of Tables

Table 1. Global Hip Osteoarthritis Pain Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Hip Osteoarthritis Pain Drug by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Hip Osteoarthritis Pain Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Market Opportunities in Next Few Years

Table 5. Market Risks Analysis

Table 6. Market Drivers

Table 7. Pfizer Basic Information, Manufacturing Base and Competitors

Table 8. Pfizer Hip Osteoarthritis Pain Drug Major Business

Table 9. Pfizer Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 10. Pfizer SWOT Analysis

Table 11. Pfizer Hip Osteoarthritis Pain Drug Product and Services

Table 12. Pfizer Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 13. Horizon Pharma Basic Information, Manufacturing Base and Competitors

Table 14. Horizon Pharma Hip Osteoarthritis Pain Drug Major Business

Table 15. Horizon Pharma Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 16. Horizon Pharma SWOT Analysis

Table 17. Horizon Pharma Hip Osteoarthritis Pain Drug Product and Services

Table 18. Horizon Pharma Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 19. Bayer Basic Information, Manufacturing Base and Competitors

Table 20. Bayer Hip Osteoarthritis Pain Drug Major Business

Table 21. Bayer Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 22. Bayer SWOT Analysis

Table 23. Bayer Hip Osteoarthritis Pain Drug Product and Services

Table 24. Bayer Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 25. Johnson and Johnson Basic Information, Manufacturing Base and Competitors

Table 26. Johnson and Johnson Hip Osteoarthritis Pain Drug Major Business

Table 27. Johnson and Johnson Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 28. Johnson and Johnson SWOT Analysis

Table 29. Johnson and Johnson Hip Osteoarthritis Pain Drug Product and Services

Table 30. Johnson and Johnson Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 31. Sanofi Basic Information, Manufacturing Base and Competitors

Table 32. Sanofi Hip Osteoarthritis Pain Drug Major Business

Table 33. Sanofi Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 34. Sanofi SWOT Analysis

Table 35. Sanofi Hip Osteoarthritis Pain Drug Product and Services

Table 36. Sanofi Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 37. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table 38. GlaxoSmithKline Hip Osteoarthritis Pain Drug Major Business

Table 39. GlaxoSmithKline Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 40. GlaxoSmithKline SWOT Analysis

Table 41. GlaxoSmithKline Hip Osteoarthritis Pain Drug Product and Services

Table 42. GlaxoSmithKline Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 43. Mylan Basic Information, Manufacturing Base and Competitors

Table 44. Mylan Hip Osteoarthritis Pain Drug Major Business

Table 45. Mylan Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 46. Mylan SWOT Analysis

Table 47. Mylan Hip Osteoarthritis Pain Drug Product and Services

Table 48. Mylan Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 49. Novartis Basic Information, Manufacturing Base and Competitors

Table 50. Novartis Hip Osteoarthritis Pain Drug Major Business

Table 51. Novartis Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 52. Novartis SWOT Analysis

Table 53. Novartis Hip Osteoarthritis Pain Drug Product and Services

Table 54. Novartis Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 55. Eli Lilly Basic Information, Manufacturing Base and Competitors

Table 56. Eli Lilly Hip Osteoarthritis Pain Drug Major Business

Table 57. Eli Lilly Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 58. Eli Lilly SWOT Analysis

Table 59. Eli Lilly Hip Osteoarthritis Pain Drug Product and Services

Table 60. Eli Lilly Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 61. Abbott Basic Information, Manufacturing Base and Competitors

Table 62. Abbott Hip Osteoarthritis Pain Drug Major Business

Table 63. Abbott Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 64. Abbott SWOT Analysis

Table 65. Abbott Hip Osteoarthritis Pain Drug Product and Services

Table 66. Abbott Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 67. Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 68. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Major Business

Table 69. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 70. Tide Pharmaceutical SWOT Analysis

Table 71. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Product and Services

Table 72. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 73. Abiogen Pharma Basic Information, Manufacturing Base and Competitors

Table 74. Abiogen Pharma Hip Osteoarthritis Pain Drug Major Business

Table 75. Abiogen Pharma Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 76. Abiogen Pharma SWOT Analysis

Table 77. Abiogen Pharma Hip Osteoarthritis Pain Drug Product and Services

Table 78. Abiogen Pharma Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 79. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors

Table 80. Daiichi Sankyo Hip Osteoarthritis Pain Drug Major Business

Table 81. Daiichi Sankyo Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 82. Daiichi Sankyo SWOT Analysis

Table 83. Daiichi Sankyo Hip Osteoarthritis Pain Drug Product and Services

Table 84. Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 85. Iroko Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table 86. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Major Business

Table 87. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 88. Iroko Pharmaceuticals SWOT Analysis

Table 89. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Product and Services

Table 90. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 91. Astellas Pharma Basic Information, Manufacturing Base and Competitors

Table 92. Astellas Pharma Hip Osteoarthritis Pain Drug Major Business

Table 93. Astellas Pharma Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 94. Astellas Pharma SWOT Analysis

Table 95. Astellas Pharma Hip Osteoarthritis Pain Drug Product and Services

Table 96. Astellas Pharma Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 97. TEVA Basic Information, Manufacturing Base and Competitors

Table 98. TEVA Hip Osteoarthritis Pain Drug Major Business

Table 99. TEVA Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 100. TEVA SWOT Analysis

Table 101. TEVA Hip Osteoarthritis Pain Drug Product and Services

Table 102. TEVA Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 103. Hengrui Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 104. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Major Business

Table 105. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 106. Hengrui Pharmaceutical SWOT Analysis

Table 107. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Product and Services

Table 108. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 109. Almatica Pharma Hip Osteoarthritis Pain Drug Type and Application

Table 110. Almatica Pharma Hip Osteoarthritis Pain Drug Major Business

Table 111. Almatica Pharma Hip Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 112. Almatica Pharma SWOT Analysis

Table 113. Almatica Pharma Hip Osteoarthritis Pain Drug Product and Services

Table 114. Almatica Pharma Hip Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 115. Global Hip Osteoarthritis Pain Drug Sales by Manufacturer (2018-2019) (K Units)

Table 116. Global Hip Osteoarthritis Pain Drug Revenue by Manufacturer (2018-2019) (USD Million)

Table 117. Global Hip Osteoarthritis Pain Drug Sales by Regions (2015-2020) (K Units)

Table 118. Global Hip Osteoarthritis Pain Drug Sales Market Share by Regions (2015-2020)

Table 119. Global Hip Osteoarthritis Pain Drug Revenue by Regions (2015-2020) (USD Million)

Table 120. North America Hip Osteoarthritis Pain Drug Sales by Countries (2015-2020) (K Units)

Table 121. North America Hip Osteoarthritis Pain Drug Sales Market Share by Countries (2015-2020)

Table 122. North America Hip Osteoarthritis Pain Drug Revenue by Countries (2015-2020) (USD Million)

Table 123. North America Hip Osteoarthritis Pain Drug Revenue Market Share by Countries (2015-2020)

Table 124. Europe Hip Osteoarthritis Pain Drug Sales by Countries (2015-2020) (K Units)

Table 125. Europe Hip Osteoarthritis Pain Drug Sales Market Share by Countries (2015-2020)

Table 126. Europe Hip Osteoarthritis Pain Drug Revenue by Countries (2015-2020) (USD Million)

Table 127. Asia-Pacific Hip Osteoarthritis Pain Drug Sales by Regions (2015-2020) (K Units)

Table 128. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share by Regions (2015-2020)

Table 129. Asia-Pacific Hip Osteoarthritis Pain Drug Revenue by Regions (2015-2020) (USD Million)

Table 130. South America Hip Osteoarthritis Pain Drug Sales by Countries (2015-2020) (K Units)

Table 131. South America Hip Osteoarthritis Pain Drug Sales Market Share by Countries (2015-2020)

Table 132. South America Hip Osteoarthritis Pain Drug Revenue by Countries (2015-2020) (USD Million)

Table 133. South America Hip Osteoarthritis Pain Drug Revenue Market Share by Countries (2015-2020)

Table 134. Middle East & Africa Hip Osteoarthritis Pain Drug Sales by Countries (2015-2020) (K Units)

Table 135. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Market Share by Countries (2015-2020)

Table 136. Middle East & Africa Hip Osteoarthritis Pain Drug Revenue by Countries (2015-2020) (USD Million)

Table 137. Middle East & Africa Hip Osteoarthritis Pain Drug Revenue Market Share by Countries (2015-2020)

Table 138. Global Hip Osteoarthritis Pain Drug Sales by Type (2015-2020) (K Units)

Table 139. Global Hip Osteoarthritis Pain Drug Sales Share by Type (2015-2020)

Table 140. Global Hip Osteoarthritis Pain Drug Revenue by Type (2015-2020) (USD Million)

Table 141. Global Hip Osteoarthritis Pain Drug Revenue Share by Type (2015-2020)

Table 142. Global Hip Osteoarthritis Pain Drug Sales by Application (2015-2020) (K Units)

Table 143. Global Hip Osteoarthritis Pain Drug Sales Share by Application (2015-2020)

Table 144. Global Hip Osteoarthritis Pain Drug Sales Forecast by Regions (2021-2025) (K Units)

Table 145. Global Hip Osteoarthritis Pain Drug Market Share Forecast by Regions (2021-2025)

Table 146. Global Hip Osteoarthritis Pain Drug Sales Forecast by Type (2021-2025) (K Units)

Table 147. Global Hip Osteoarthritis Pain Drug Market Share Forecast by Type (2021-2025)

Table 148. Global Hip Osteoarthritis Pain Drug Sales Forecast by Application (2021-2025)

Table 149. Global Hip Osteoarthritis Pain Drug Market Share Forecast by Application (2021-2025)

Table 150. Direct Channel Pros & Cons

Table 151. Indirect Channel Pros & Cons

Table 152. Distributors/Traders/ Dealers List

List of Figures

Figure 1. Hip Osteoarthritis Pain Drug Picture

Figure 2. Global Sales Market Share of Hip Osteoarthritis Pain Drug by Type in 2019

Figure 3. Oral Picture

Figure 4. Injection Picture

Figure 5. External Picture

Figure 6. Hip Osteoarthritis Pain Drug Sales Market Share by Application in 2018

Figure 7. Medical Care Picture

Figure 8. Personal Care Picture

Figure 9. Global Hip Osteoarthritis Pain Drug Market Status and Outlook (2015-2025) (USD Million)

Figure 10. United States Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 11. Canada Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 12. Mexico Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 13. Germany Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 14. France Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 15. UK Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 16. Russia Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 17. Italy Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 18. China Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 19. Japan Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 20. Korea Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 21. India Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 22. Southeast Asia Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 23. Australia Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)

Figure 24. Brazil Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 25. Egypt Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 26. Saudi Arabia Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 27. South Africa Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 28. Turkey Hip Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 29. Global Hip Osteoarthritis Pain Drug Sales Market Share by Manufacturer in 2019

Figure 30. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Manufacturer in 2019

Figure 31. Top 3 Hip Osteoarthritis Pain Drug Manufacturer (Revenue) Market Share in 2019

Figure 32. Top 6 Hip Osteoarthritis Pain Drug Manufacturer (Revenue) Market Share in 2019

Figure 33. Key Manufacturer Market Share Trend

Figure 34. Global Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 35. Global Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2015-2020) (USD Million)

Figure 36. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Regions (2015-2020)

Figure 37. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Regions in 2018

Figure 38. North America Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

Figure 39. Europe Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

Figure 40. Asia-Pacific Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

Figure 41. South America Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

Figure 42. Middle East & Africa Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

Figure 43. North America Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2015-2020) (USD Million)

Figure 44. North America Hip Osteoarthritis Pain Drug Sales Market Share by Countries (2015-2020)

Figure 45. North America Hip Osteoarthritis Pain Drug Sales Market Share by Countries in 2018

Figure 46. North America Hip Osteoarthritis Pain Drug Revenue Market Share by Countries (2015-2020) (USD Million)

Figure 47. North America Hip Osteoarthritis Pain Drug Revenue Market Share by Countries in 2018

Figure 48. United States Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 49. Canada Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 50. Mexico Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 51. Europe Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2015-2020) (USD Million)

Figure 52. Europe Hip Osteoarthritis Pain Drug Revenue Market Share by Countries (2015-2020)

Figure 53. Europe Hip Osteoarthritis Pain Drug Revenue Market Share by Countries in 2019

Figure 54. Germany Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 55. UK Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 56. France Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 57. Russia Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 58. Italy Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 59. Asia-Pacific Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2015-2020) (USD Million)

Figure 60. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Market Share by Regions 2019

Figure 61. Asia-Pacific Hip Osteoarthritis Pain Drug Revenue Market Share by Regions 2019

Figure 62. China Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 63. Japan Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 64. Korea Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 65. India Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 66. Southeast Asia Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 67. South America Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2015-2020) (USD Million)

Figure 68. South America Hip Osteoarthritis Pain Drug Sales Market Share by Countries in 2019

Figure 69. South America Hip Osteoarthritis Pain Drug Revenue Market Share by Countries in 2019

Figure 70. Brazil Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 71. Argentina Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 72. Middle East and Africa Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2015-2020) (USD Million)

Figure 73. Middle East and Africa Hip Osteoarthritis Pain Drug Sales Market Share by Countries in 2019

Figure 74. Middle East and Africa Hip Osteoarthritis Pain Drug Revenue Market Share by Countries (2015-2020)

Figure 75. Middle East and Africa Hip Osteoarthritis Pain Drug Revenue Market Share by Countries in 2019

Figure 76. Saudi Arabia Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 77. Egypt Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 78. Turkey Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 79. South Africa Hip Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 80. Global Hip Osteoarthritis Pain Drug Sales and Growth Rate (2021-2025) (K Units)

Figure 81. Global Hip Osteoarthritis Pain Drug Revenue and Growth Rate (2021-2025) (USD Million)

Figure 82. North America Sales Hip Osteoarthritis Pain Drug Market Forecast (2021-2025) (K Units)

Figure 83. Europe Sales Hip Osteoarthritis Pain Drug Market Forecast (2021-2025) (K Units)

Figure 84. Asia-Pacific Sales Hip Osteoarthritis Pain Drug Market Forecast (2021-2025) (K Units)

Figure 85. South America Sales Hip Osteoarthritis Pain Drug Market Forecast (2021-2025) (K Units)

Figure 86. Middle East & Africa Sales Hip Osteoarthritis Pain Drug Market Forecast (2021-2025) (K Units)

Figure 87. Sales Channel: Direct Channel vs Indirect Channel